Search Results 231-240 of 16999 for Hepatic flexure

1. A Study to Evaluate Non-invasive Biomarkers of Metabolic Liver Disease - Mayo Clinic

   The imaging biomarkers will cover an array of methods that could be applicable to non-alcoholic fatty liver disease (NAFLD), including liver fat, liver ...

2. A Study to Evaluate the Effectiveness and Safety of CC-90001 in Subjects With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis - Mayo Clinic

   A Study to Evaluate the Effectiveness and Safety of CC-90001 in Subjects With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis · Overview · Participation ...

3. A Study of Short-term Survival in Subjects With Acute-on-chronic Liver Failure After Plasma Exchange With Human Serum Albumin 5% - Mayo Clinic

   The purpose of this study is to evaluate the effects of plasma exchange using human serum albumin 5% (PE-A 5%) in acute-on-chronic liver failure (ACLF) subjects ...

4. Hepatocellular Carcinoma (HCC) Clinical Trials - Mayo Clinic Research

   ... liver disease (AEF, fECS) and that improve iodine signal (vMono+) on detecting liver fibrosis and hepatic masses or esophageal varices, in comparison to ...

5. Nonalcoholic fatty liver disease - Doctors and departments - Mayo Clinic

   This liver condition is becoming more common in the Western world. Find out how to treat and prevent this potentially dangerous liver disease.

6. Mayo Clinic Radio: Liver transplant and organ donation / clinical trials / constipation

   ... liver disease. In rare cases, sudden failure of a previously normal liver may occur. The liver is just one of several organs, including kidney, heart and ...

7. Gastroenterology and Hepatology - Clinical trials

   Rochester, Minn. About this study. Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world and a major public ...

8. Digestive Diseases Clinical Trials - Medical Professionals

   Potentially Resectable Pancreatic Cancer - No involvement of the celiac artery, common hepatic artery, and superior mesenteric artery (SMA) and, if present, ...

9. Nonalcoholic fatty liver disease - Doctors and departments - Mayo Clinic

   This liver condition is becoming more common in the Western world. Find out how to treat and prevent this potentially dangerous liver disease.

10. Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD) - Mayo Clinic

    Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD) · Overview · Participation eligibility · Participating Mayo Clinic ...